Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases

Personalized therapy for bone metastases should consider the patients’ remaining lifespan. Estimation of survival can be facilitated with scoring tools. A new tool was developed, specifically designed to estimate 12- month survival.